Related Experiment Videos
Skeletal muscle as an artificial endocrine tissue
1Basic Medical Sciences and Department of Surgery, Royal Free and University College Medical School, Royal Free Campus, University of London, London, UK. goldspink@rfc.ucl.ac.uk
Summary
Muscle tissue can express engineered genes, offering prolonged therapeutic protein production. This gene therapy approach avoids repeated injections, but safety concerns require further investigation.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Muscle tissue's capacity for gene expression and prolonged protein half-life.
- Potential for systemic circulation of muscle-expressed gene products.
- Limitations of traditional peptide/protein therapy due to short half-life and repeated injections.
Purpose of the Study:
- To explore the potential of engineered genes in muscle for therapeutic factor production.
- To evaluate muscle as a bioreactor for producing medicinal proteins/peptides.
- To discuss the advantages of muscle-based gene therapy over conventional methods.
Main Methods:
- Delivery of engineered genes via intramuscular injection of plasmid or viral vectors.
- Introduction of transfected myoblasts for gene expression.
- Utilizing transfected myoblasts in bioreactors for in vitro protein/peptide production.
Main Results:
- Demonstrated muscle's ability to uptake and express engineered genes, leading to prolonged expression.
- Observed entry of gene products into systemic circulation, enabling alteration of endocrine and paracrine factors.
- Highlighted advantages of muscle-based production over bacterial expression systems.
Conclusions:
- Muscle gene therapy offers a promising alternative to repeated protein injections.
- Further research is needed to address safety considerations for clinical gene therapy applications.
- Muscle tissue presents a viable platform for in vivo and in vitro therapeutic protein production.